Author:
Al-Kinani Khalid Kadhem,Jassim Zainab Eassa,Taher Salam Shanta,Hussein Ahmed Abbass
Subject
Pharmaceutical Science,Pharmacy,Education
Reference34 articles.
1. 1. Mustafa NE, Elmahi OM, Waggiallah HA, Eltayeb LB. Kermes Dye Extract from Coccus Ilicis Insect as An Alternative Counter Stain Instead of Eosin in Various Tissue Constituents: An Experimental Study. Pharmacophore. 2020;11(5):14-9.
2. 2. EMA Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance: non-clinical and clinical issues. EMEA/CHMP/BMWP/42832/2005 Rev1 2014, 1-16. doi:10.1089/blr.2011.9970.
3. 3. Jung EH, Sarpatwari A, Ph DJD, Kesselheim AS, Sinha MS. FDA, and EMA Biosimilar Approvals. J Gen Intern Med. 2019;351:2-4. doi:10.1007/s11606-019-05408-6.
4. 4. Berkowitz SA, Houde DJ. The complexity of protein structure and the challenges it poses in developing biopharmaceuticals. InBiophysical Characterization of Proteins in Developing Biopharmaceuticals. 2020:3-26. ISBN 9780444641731.
5. 5. Vulto AG, Jaquez OA. The process defines the product: what really matters in biosimilar design and production?. Rheumatology. 2017;56(suppl_4):iv14-29. doi:10.1093/rheumatology/kex278.